Potrero Medical, Inc.
Accuryn Medical is dedicated to transforming patient care through innovative monitoring systems that enable early detection and prevention of critical conditions such as acute kidney injury (AKI). Their mission is to help healthcare providers protect the kidney by providing real-time, actionable data via their advanced sensor-integrated Foley catheter platform, which enhances diagnostic strategies and improves patient outcomes. The company also emphasizes the importance of physician intuition, teamwork, and the integration of technology to improve clinical care and physician wellbeing, especially in high-stakes environments like cardiac surgery and critical care.
Industries
Nr. of Employees
small (1-50)
Potrero Medical, Inc.
Products
Sensor-integrated urinary catheter monitoring platform (catheter, bedside monitor, remote visualization)
A monitoring platform consisting of a urinary catheter with integrated sensors, bedside physiologic monitor, and remote visualization display that together provide continuous urine-output, intra-abdominal pressure, and core temperature monitoring with trend visualization and annotation.
Clinical analytics and diagnostic applications for AKI and protocolized workflows
Software applications integrated with monitoring platforms that provide protocolized clinical tools (for example, risk scoring and stress-test modules), predictive models for AKI, and annotation workflows to support ICU and nephrology teams.
Sensor-integrated urinary catheter monitoring platform (catheter, bedside monitor, remote visualization)
A monitoring platform consisting of a urinary catheter with integrated sensors, bedside physiologic monitor, and remote visualization display that together provide continuous urine-output, intra-abdominal pressure, and core temperature monitoring with trend visualization and annotation.
Clinical analytics and diagnostic applications for AKI and protocolized workflows
Software applications integrated with monitoring platforms that provide protocolized clinical tools (for example, risk scoring and stress-test modules), predictive models for AKI, and annotation workflows to support ICU and nephrology teams.
Services
Coordination and data collection for a multi-center registry linking continuous physiologic monitoring data with clinical outcomes to support research and clinical validation.
On-demand training videos, instructions for use, documentation, personalized demos, and consultative implementation to support clinical integration, workflow optimization, and pilot deployments.
Short-term loan and deployment of monitoring systems to support hospitals during infectious-disease surges, enabling continuous physiologic monitoring while reducing room entry.
Partnerships with clinical investigators and operational support for site participation in registries and investigator-led studies to generate peer-reviewed evidence.
Consultative services to integrate hemodynamic monitoring, optimize perioperative and ICU workflows, apply human-factors principles, and align alerting to clinician practice to improve adoption and reduce cognitive burden.
Simulation programs for resident procedural training (including echocardiography) and family/support-person education to improve trainee readiness and provide support-persons with context about clinical workflows.
Coordination and data collection for a multi-center registry linking continuous physiologic monitoring data with clinical outcomes to support research and clinical validation.
On-demand training videos, instructions for use, documentation, personalized demos, and consultative implementation to support clinical integration, workflow optimization, and pilot deployments.
Short-term loan and deployment of monitoring systems to support hospitals during infectious-disease surges, enabling continuous physiologic monitoring while reducing room entry.
Partnerships with clinical investigators and operational support for site participation in registries and investigator-led studies to generate peer-reviewed evidence.
Consultative services to integrate hemodynamic monitoring, optimize perioperative and ICU workflows, apply human-factors principles, and align alerting to clinician practice to improve adoption and reduce cognitive burden.
Simulation programs for resident procedural training (including echocardiography) and family/support-person education to improve trainee readiness and provide support-persons with context about clinical workflows.
Expertise Areas
- Continuous physiologic monitoring in critical care
- Acute kidney injury early detection and management
- Intra-abdominal pressure monitoring and abdominal compartment syndrome detection
- EHR-based AKI surveillance and automated phenotyping
Key Technologies
- Continuous urine-output sensing
- Continuous intra-abdominal pressure measurement
- Catheter-integrated sensor systems
- Active drain-line clearance mechanisms
News & Updates
Potrero Medical announced that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, aimed at early prediction of AKI in cardiac ICU patients.
Potrero Medical was highlighted by ASN as part of the AKI Spotlight Innovation at Kidney Week, emphasizing their contribution to AKI management.
An article discussing the challenges and needs for AI in healthcare, especially in early AKI detection, highlighting issues with reliance on serum creatinine and data standardization.
Potrero Medical was recognized by ASN for their innovative approach to AKI detection and management, showcasing their contributions to nephrology.
The FDA granted Breakthrough Device Designation to Potrero Medical for their AKI prediction machine learning algorithm, marking a significant milestone in AKI management.
Potrero Medical was recognized as one of the most promising private med tech companies in 2018 by FierceMedTech.
Potrero Medical announced that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, aimed at early prediction of AKI in cardiac ICU patients.
Potrero Medical was highlighted by ASN as part of the AKI Spotlight Innovation at Kidney Week, emphasizing their contribution to AKI management.
An article discussing the challenges and needs for AI in healthcare, especially in early AKI detection, highlighting issues with reliance on serum creatinine and data standardization.
Potrero Medical was recognized by ASN for their innovative approach to AKI detection and management, showcasing their contributions to nephrology.
The FDA granted Breakthrough Device Designation to Potrero Medical for their AKI prediction machine learning algorithm, marking a significant milestone in AKI management.
Potrero Medical was recognized as one of the most promising private med tech companies in 2018 by FierceMedTech.